Clinical Trials Directory

Trials / Unknown

UnknownNCT02687074

Effects of HFNC on Moderate and Severe Respiratory Failure Patients

Effects of High Flow Nasal Canula on Moderate and Severe Respiratory Failure Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
246 (estimated)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Respiratory failure is the danger for the patients admitted in ICU, mechanical ventilation could save a lot of patients' life, however, it prolongs patients' ICU stay and hospital stay. High flow nasal cannula (HFNC) has advantages of PEEP effects, reducing dead space, increasing EELV and improving comfort, and it has been used to treat respiratory failure patients. In recent study, HFNC could improve mortality of respiratory failure patients with P/F\<200mmHg in the subgroup. The investigators want to start a randomized controlled study to evaluate the effects of HFNC on the patients with respiratory failure.

Detailed description

just as the brief summary

Conditions

Interventions

TypeNameDescription
DEVICEHFNCpatients treated with high flow nasal cannula
DEVICENIVpatients treated with noninvasive ventilation

Timeline

Start date
2016-01-01
Primary completion
2016-12-01
Completion
2017-12-01
First posted
2016-02-22
Last updated
2016-02-22

Source: ClinicalTrials.gov record NCT02687074. Inclusion in this directory is not an endorsement.